These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 7540486)

  • 21. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis].
    Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A
    Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antiperinuclear and antikeratin antibodies in liver diseases].
    Youinou P; Miossec P; Pennec Y; Boles JM; Le Goff P; Le Menn G
    Sem Hop; 1983 Mar; 59(9):589-92. PubMed ID: 6190231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
    Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
    Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiperinuclear factor--clinical, serological and genetic correlates in Israeli patients with rheumatoid arthritis.
    Tishler M; Maran R; Langevitz P; Livneh A; Gazit E; Gilburd B; Youinou P; Shoenfeld Y
    Rheumatol Int; 1997; 17(4):141-3. PubMed ID: 9440144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amtiperinuclear factor and antikeratin antibody: diagnostic use in a clinical laboratory setting.
    Alnigenis MN; Warikoo S; Barland P
    J Rheumatol; 2000 Aug; 27(8):2056-7. PubMed ID: 10955361
    [No Abstract]   [Full Text] [Related]  

  • 26. [Class II HLA antigens and rheumatoid factors in rheumatoid polyarthritis. Inverse influence of DR4 and DR7 antigens?].
    Cohen JH; Blanchard F; Vischer TL
    Rev Rhum Mal Osteoartic; 1986 Nov; 53(11):639-41. PubMed ID: 3497427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
    Liu X; Jia R; Zhao J; Li Z
    J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [High titers of rheumatoid factor: clinical significance].
    Naranjo Hernández A; Rodríguez González T; Rodríguez-Lozano C; Ojeda Bruno S; Francisco Hernández F; Sánchez-García F; Bilbao Cantarero A
    Rev Clin Esp; 1997 Apr; 197(4):232-6. PubMed ID: 9254397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of antikeratin antibodies in Greek patients with rheumatoid arthritis. A clinical, serologic, and immunogenetic study.
    Boki KA; Kurki P; Holthofer H; Tzioufas AG; Drosos AA; Moutsopoulos HM
    J Rheumatol; 1995 Nov; 22(11):2046-8. PubMed ID: 8596142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antiperinuclear factors in psoriasis. Correlation with other serological abnormalities in 90 patients].
    Youinou P; Massé R; Peu-Duvallon P; Le Roux P; Grulier A; Miossec P; Dorval JC; Lizan G; Férec C; Le Goff P
    Ann Dermatol Venereol; 1982; 109(4):359-64. PubMed ID: 6751193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical usefulness of rheumatoid factor in synovial fluid. Re-evaluation].
    Sari L; Astorga G; Carvajal P; Gatica H
    Rev Med Chil; 1993 Dec; 121(12):1374-81. PubMed ID: 8085060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiperinuclear factor--a specific marker for rheumatoid arthritis.
    Nesher G
    Isr J Med Sci; 1997 Apr; 33(4):267-8. PubMed ID: 9347877
    [No Abstract]   [Full Text] [Related]  

  • 33. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A; Plischke H; Kellner H; Gruber R
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection.
    Kessel A; Rosner I; Zuckerman E; Golan TD; Toubi E
    J Rheumatol; 2000 Mar; 27(3):610-2. PubMed ID: 10743797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relationship between HLA-DR4/1 subtypes and T cell response to influenza virus hemagglutinin or anti-HA308-317 antibodies in rheumatoid arthritis].
    Li X; Li R; Li ZG
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(27):1881-3. PubMed ID: 19039998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test?
    Panchagnula R; Rajiv SR; Prakash J; Chandrashekara S; Suresh KP
    J Clin Rheumatol; 2006 Aug; 12(4):172-5. PubMed ID: 16891919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seronegative rheumatoid arthritis and HLA-DR4: proposal for criteria.
    Gran JT; Husby G
    J Rheumatol; 1987 Dec; 14(6):1079-82. PubMed ID: 3325639
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical evaluation of immuno-serological laboratory data].
    Kasukawa R; Tojo J; Kuwana T; Obara K
    Rinsho Byori; 1996 Dec; 44(12):1157-63. PubMed ID: 8990934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-DR1, DR4, and DRB1 disease related subtypes in rheumatoid arthritis. Association with susceptibility but not severity in a city wide community based study.
    Suarez-Almazor ME; Tao S; Moustarah F; Russell AS; Maksymowych W
    J Rheumatol; 1995 Nov; 22(11):2027-33. PubMed ID: 8596139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis and therapy of rheumatoid arthritis].
    Azuma I
    Arerugi; 1993 Dec; 42(12):1749-53. PubMed ID: 8110035
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.